Glenmark launches biosimilar of anti-diabetic drug, vows to cut down therapy cost by 70% on January 3, 2024 at 4:50 am

Priced at around Rs 100 for a standard dose of 1.2 mg (per day), this will lower the cost of therapy by approximately 70 percent